Entrepreneur's Course: Navigating Both Calm And Choppy Seas

Arden Kelton has developed his sea legs as an entrepreneur by riding out high and low tides. Kelton, who holds a Ph.D. in medical physics from the University of California, Los Angeles, is founder and president of Lamplighter Industries Inc. The Yanceyville, N.C., firm uses a ceramic technology invented by Kelton's partner, engineer David Emmett, to manufacture electronic display lighting for instrument light panels. During recent weeks, Kelton has been scrambling to do something that for a lot

Written bySuzanne Hagan
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Despite his recent financial problems, Kelton has not lost his entrepreneurial spirit. "Money doesn't matter an awful lot; it's really the project's meaning," he says. "I believe in the company's future, and I do have confidence that if the financing fails, we'll come up with a buyer.

"There's a creative process in starting a business. You could say that I enjoy starting a business more than running it, yet I have no intention of leaving Lamplighter unless it's a good move for my employees and my investors."

Kelton's course as an entrepreneur is fixed, it seems. Lamplighter is the fourth company he has started; he even looks forward to launching his next venture, probably in biotechnology. But not all scientists who become entrepreneurs yearn for another voyage. Garland Marshall, for example, once was at the helm of a company that reached a safe harbor, yet he's now a confirmed landlubber.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies